A new trading day began on Tuesday, with AIM ImmunoTech Inc (AMEX: AIM) stock price down -4.36% from the previous day of trading, before settling in for the closing price of $1.32. AIM’s price has ranged from $1.21 to $36.00 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 34.59%. Meanwhile, its annual earnings per share averaged 75.00%. With a float of $2.82 million, this company’s outstanding shares have now reached $2.94 million.
AIM ImmunoTech Inc (AIM) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of AIM ImmunoTech Inc is 4.06%, while institutional ownership is 3.65%. The most recent insider transaction that took place on Apr 04 ’25, was worth 2,583. In this transaction CEO & President of this company bought 41,000 shares at a rate of $0.06, taking the stock ownership to the 1,899,029 shares. Before that another transaction happened on Apr 04 ’25, when Company’s COO, Secretary, Gen. Counsel bought 500 for $0.09, making the entire transaction worth $44. This insider now owns 401,762 shares in total.
AIM ImmunoTech Inc (AIM) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -10 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 75.00% per share during the next fiscal year.
AIM ImmunoTech Inc (AMEX: AIM) Trading Performance Indicators
Here are AIM ImmunoTech Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 33.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -20.16, a number that is poised to hit -0.94 in the next quarter and is forecasted to reach -4.33 in one year’s time.
Technical Analysis of AIM ImmunoTech Inc (AIM)
The latest stats from [AIM ImmunoTech Inc, AIM] show that its last 5-days average volume of 0.39 million was superior to 81160.0 than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 27.43%.
During the past 100 days, AIM ImmunoTech Inc’s (AIM) raw stochastic average was set at 2.82%, which indicates a significant decrease from 16.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0974 in the past 14 days, which was lower than the 0.1569 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6628, while its 200-day Moving Average is $5.0908. Now, the first resistance to watch is $1.3167. This is followed by the second major resistance level at $1.3733. The third major resistance level sits at $1.4267. If the price goes on to break the first support level at $1.2067, it is likely to go to the next support level at $1.1533. The third support level lies at $1.0967 if the price breaches the second support level.
AIM ImmunoTech Inc (AMEX: AIM) Key Stats
With a market capitalization of 3.70 million, the company has a total of 2,853K Shares Outstanding. Currently, annual sales are 170 K while annual income is -17,320 K. The company’s previous quarter sales were 30 K while its latest quarter income was -3,280 K.
